Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Global Chemical Safety Issues Scrutinized during Insightful Helsinki Chemicals Forum 2013

Published: Wednesday, July 24, 2013
Last Updated: Wednesday, July 24, 2013
Bookmark and Share
Conference encourages green alternatives to reduce toxic chemicals in the EU and drive chemical safety.

Scientists know that while the end-products they develop need to be safe for use, often the research and development path is not.  Sometimes toxic chemical mixtures and compounds are used to create the final product or drive the experiment methodology.  It may be the nature of the beast, so to speak, but one of the goals of the European Chemicals Agency (ECHA) and its REACH regulation is to encourage green alternatives wherever possible, reduce toxic chemicals in the EU, and drive chemical safety.   

The fifth Helsinki Chemicals Forum (HCF) is ECHA's forum for presenting topics related to REACH.  This year HCF 2013 highlighted panels on the sound international management of chemicals; chemicals in products; regulation of nano-materials; lists of chemicals of concern; and, combination effects.  HCF 2013 was held at the Helsinki Exhibition and Convention Centre from 18-19 June 2013.

Presentations were given by representatives from international chemical industry organizations and authorities, such as CEFIC, CIEL, the European Commission, OECD, ECHA, Environment Canada, and the American Chemistry Council.   Panel discussions were usually lively and sometimes heated as panelists emphasized various points of view.

"What is very important to me," stated Geert Dancet, "is that everyone is moving toward the same standards and methods so that ultimately we can start dividing the work.  At the moment there is no real division of work, so that every country has to identify which chemicals it wants to regulate.  If we would have common standards for hazards and risks and risk management, then we could start dividing the work."  

For the first time, a delegate detailed the status of current Chinese toxic chemical regulations.  Yunbo Siu, Managing Director, Chemical Inspection and Regulation Service Ltd CIRS/Ireland, presented China's developing environmental approach from pollution treatment to source elimination.  He outlined China's five-year plan on chemical environmental risk prevention and control that is currently underway, and addressed the mind-set that needs to be changed in order to successfully implement this plan.  Currently China has listed some 158 toxic chemicals that are restricted for import/export under their first Priority Hazardous Chemicals (PHC) list and is evaluating other substances for inclusion.  The audience was favorably impressed by the scope and speed with which China is addressing their environmental challenges.  

North American regulatory agencies and organizations were represented by Michael Walls, Vice President of the American Chemistry Council; Eeva Leinala, Senior Manager at Health Canada; and, Jake Sanderson, Manager, Environment Canada.  Changes to US and Canadian toxic chemical regulations and how those resemble and dovetail with European standards and regulations played a part in discussions of sound international management of chemicals.  

Next year, the Helsinki Chemicals Forum will be held from 22-23 May 2014 in Helsinki, Finland.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos